Vetoquinol Future Growth
Future criteria checks 2/6
Vetoquinol is forecast to grow earnings and revenue by 5% and 4.4% per annum respectively.
Key information
5.0%
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 14.8% |
Revenue growth rate | 4.4% |
Future return on equity | 9.7% |
Analyst coverage | Good |
Last updated | 03 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 578 | 61 | 68 | N/A | 5 |
12/31/2024 | 553 | 57 | 64 | N/A | 6 |
12/31/2023 | 529 | 56 | N/A | N/A | N/A |
9/30/2023 | 527 | 57 | N/A | N/A | N/A |
6/30/2023 | 525 | 59 | 83 | 106 | N/A |
3/31/2023 | 533 | 53 | 61 | 84 | N/A |
12/31/2022 | 540 | 48 | 40 | 63 | N/A |
9/30/2022 | 538 | 48 | 29 | 54 | N/A |
6/30/2022 | 537 | 48 | 17 | 46 | N/A |
3/31/2022 | 529 | 55 | 37 | 68 | N/A |
12/31/2021 | 521 | 63 | 57 | 90 | N/A |
9/30/2021 | 504 | 52 | -1 | 91 | N/A |
6/30/2021 | 487 | 40 | -59 | 93 | N/A |
3/31/2021 | 457 | 30 | -56 | 93 | N/A |
12/31/2020 | 427 | 19 | -53 | 92 | N/A |
9/30/2020 | 418 | 25 | 5 | 85 | N/A |
6/30/2020 | 408 | 31 | 64 | 78 | N/A |
3/31/2020 | 402 | 30 | 51 | 65 | N/A |
12/31/2019 | 396 | 29 | 38 | 52 | N/A |
9/30/2019 | 385 | 31 | 28 | 43 | N/A |
6/30/2019 | 374 | 33 | 19 | 35 | N/A |
3/31/2019 | 371 | 35 | 21 | 36 | N/A |
12/31/2018 | 368 | 36 | 24 | 38 | N/A |
9/30/2018 | 360 | 36 | 25 | 38 | N/A |
6/30/2018 | 352 | 36 | 27 | 39 | N/A |
3/31/2018 | 352 | 36 | 27 | 40 | N/A |
12/31/2017 | 352 | 35 | 28 | 41 | N/A |
9/30/2017 | 354 | 32 | N/A | 41 | N/A |
6/30/2017 | 356 | 29 | N/A | 40 | N/A |
3/31/2017 | 353 | 28 | N/A | 42 | N/A |
12/31/2016 | 350 | 28 | N/A | 43 | N/A |
9/30/2016 | 349 | 27 | N/A | 46 | N/A |
6/30/2016 | 348 | 25 | N/A | 49 | N/A |
3/31/2016 | 345 | 25 | N/A | 44 | N/A |
12/31/2015 | 343 | 24 | N/A | 39 | N/A |
9/30/2015 | 338 | 26 | N/A | N/A | N/A |
6/30/2015 | 333 | 28 | N/A | 38 | N/A |
3/31/2015 | 324 | 27 | N/A | 40 | N/A |
12/31/2014 | 315 | 26 | N/A | 41 | N/A |
9/30/2014 | 309 | 25 | N/A | N/A | N/A |
6/30/2014 | 304 | 24 | N/A | 32 | N/A |
3/31/2014 | 302 | 24 | N/A | 30 | N/A |
12/31/2013 | 300 | 24 | N/A | 28 | N/A |
9/30/2013 | 298 | 22 | N/A | 28 | N/A |
6/30/2013 | 297 | 21 | N/A | 29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0O1O's forecast earnings growth (5% per year) is above the savings rate (1.6%).
Earnings vs Market: 0O1O's earnings (5% per year) are forecast to grow slower than the UK market (12.3% per year).
High Growth Earnings: 0O1O's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0O1O's revenue (4.4% per year) is forecast to grow faster than the UK market (3.4% per year).
High Growth Revenue: 0O1O's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0O1O's Return on Equity is forecast to be low in 3 years time (9.7%).